Remove 2006 Remove Clinical Pharmacology Remove Therapies
article thumbnail

Metabolism of macrocyclic drugs

Metabolite Tales Blog

A combination therapy of glecaprevir and pibrentasvir has recently been implicated in a case of liver injury. Figure 2 Human metabolism of glecaprevir Involvement of gut bacteria Grazoprevir (MK5172) is also used as part of combination therapy to treat chronic hepatitis C. link] [13] A user’s guide to lorlatinib. Nagasaka et al.,

Drugs 52
article thumbnail

Metabolism of de novo designed macrocyclic drugs

Metabolite Tales Blog

A combination therapy of glecaprevir and pibrentasvir has recently been implicated in a case of liver injury. Figure 2 Human metabolism of glecaprevir Involvement of gut bacteria Grazoprevir (MK5172) is also used as part of combination therapy to treat chronic hepatitis C. link] [13] A user’s guide to lorlatinib. Nagasaka et al.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Analysis Life Sciences Thank You FDA’s nonprescription advisors find no efficacy for phenylephrine

Agency IQ

The clinical trials underpinning the original determination that phenylephrine is GRASE – that is, Generally Regarded as Safe and Effective – predate the 1994 inclusion of phenylephrine hydrochloride in the final monograph for OTC nasal decongestant drug products. The two sides saw nearly every finding in a different light.

Science 40
article thumbnail

Iomeprol

New Drug Approvals

in ARKIVOC, 2006, 104 and Tetrahedron Lett., New Drug Therapy Approvals 2024 (PDF). Article ] Rosati G: Clinical pharmacology of iomeprol. 2005, 46, 7179.In In a 50 mL three-necked round-bottomed flask equipped with a thermometer and a reflux condenser, solid 3,5-disubstituted phenol 1 (16.4 1 October 2024. January 2025.

FDA 52